112 related articles for article (PubMed ID: 16457162)
1. [Docetaxel and novel strategies in the treatment of NSCLC].
Longo F; Mansueto G
Tumori; 2005; 91(6):suppl 11-22. PubMed ID: 16457162
[No Abstract] [Full Text] [Related]
2. Docetaxel in advanced non-small cell lung cancer.
Wakelee H; Ramalingam S; Belani CP
Expert Rev Anticancer Ther; 2005 Feb; 5(1):13-24. PubMed ID: 15757434
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
Csiki I; Morrow JD; Sandler A; Shyr Y; Oates J; Williams MK; Dang T; Carbone DP; Johnson DH
Clin Cancer Res; 2005 Sep; 11(18):6634-40. PubMed ID: 16166442
[TBL] [Abstract][Full Text] [Related]
4. [Docetaxel (taxotere) in non-small-cell bronchial carcinoma].
Manegold C
Med Klin (Munich); 1997 Sep; 92 Suppl 4():10-5. PubMed ID: 9446014
[TBL] [Abstract][Full Text] [Related]
5. [Toward the cure of "early-stage" solid tumors: the role of docetaxel].
Mansueto G; Longo F
Tumori; 2005; 91(4):suppl 17-28. PubMed ID: 16277113
[No Abstract] [Full Text] [Related]
6. The development of docetaxel (Taxotere) in non-small cell lung cancer.
Kris MG; Miller VA; Ng KK; Grant SC
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
[No Abstract] [Full Text] [Related]
7. Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.
Malani AK; Abou-Jawde RM; Singh J; Taylor SA
J Clin Oncol; 2007 Mar; 25(9):1143-4; author reply 1144. PubMed ID: 17369581
[No Abstract] [Full Text] [Related]
8. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
Khuri FR
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
[TBL] [Abstract][Full Text] [Related]
9. Taxanes, past, present, and future impact on non-small cell lung cancer.
Joshi M; Liu X; Belani CP
Anticancer Drugs; 2014 May; 25(5):571-83. PubMed ID: 24463482
[TBL] [Abstract][Full Text] [Related]
10. [Taxol in bronchial carcinoma].
Gatzemeier U
Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
[No Abstract] [Full Text] [Related]
11. Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
Nugent FW; Mertens WC; Graziano S; Levitan N; Collea R; Gajra A; Marshall J; McCann J
Lung Cancer; 2005 May; 48(2):267-73. PubMed ID: 15829328
[TBL] [Abstract][Full Text] [Related]
12. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Singh M
Pharm Res; 2006 Sep; 23(9):2094-106. PubMed ID: 16902813
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel in the treatment of advanced non-small-cell lung cancer.
Saloustros E; Georgoulias V
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1207-22. PubMed ID: 18699760
[TBL] [Abstract][Full Text] [Related]
14. [AIOM Conference 2004. Revision of the role of docetaxel in non-small cell lung cancer].
Gamucci T; Mansueto G
Tumori; 2004; 90(6):22-9. PubMed ID: 15762374
[No Abstract] [Full Text] [Related]
15. The current status of docetaxel for advanced non-small cell lung cancer.
Green MR
Anticancer Drugs; 2001 Feb; 12 Suppl 1():S11-6. PubMed ID: 11340898
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
Patel AR; Chougule MB; I T; Patlolla R; Wang G; Singh M
Pharm Res; 2013 May; 30(5):1435-46. PubMed ID: 23361589
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
Kris MG; Millward M
Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
[No Abstract] [Full Text] [Related]
18. Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.
Betticher DC; Rosell R
Lung Cancer; 2004 Dec; 46 Suppl 2():S23-32. PubMed ID: 15698528
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional radiotherapy and docetaxel in treatment of stage III non-small cell lung carcinoma: no good survival due to radiation pneumonitis.
Dinçbas FO; Atalar B; Koca S
Lung Cancer; 2004 Feb; 43(2):241-2. PubMed ID: 14739045
[No Abstract] [Full Text] [Related]
20. Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
Bria E; Cuppone F; Ciccarese M; Nisticò C; Facciolo F; Milella M; Izzo F; Terzoli E; Cognetti F; Giannarelli D
Cancer Treat Rev; 2006 Dec; 32(8):583-7. PubMed ID: 16919884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
